Your browser doesn't support javascript.
loading
Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation.
Yang, Rui; Chen, Lee H; Hansen, Landon J; Carpenter, Austin B; Moure, Casey J; Liu, Heng; Pirozzi, Christopher J; Diplas, Bill H; Waitkus, Matthew S; Greer, Paula K; Zhu, Huishan; McLendon, Roger E; Bigner, Darell D; He, Yiping; Yan, Hai.
Afiliação
  • Yang R; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
  • Chen LH; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
  • Hansen LJ; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
  • Carpenter AB; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
  • Moure CJ; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
  • Liu H; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
  • Pirozzi CJ; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
  • Diplas BH; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
  • Waitkus MS; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
  • Greer PK; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
  • Zhu H; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
  • McLendon RE; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
  • Bigner DD; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina.
  • He Y; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina. hai.yan@duke.edu yiping.he@duke.edu.
  • Yan H; Department of Pathology and the Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina. hai.yan@duke.edu yiping.he@duke.edu.
Cancer Res ; 77(22): 6097-6108, 2017 11 15.
Article em En | MEDLINE | ID: mdl-28939681
ABSTRACT
Inactivating mutations in the transcriptional repression factor Capicua (CIC) occur in approximately 50% of human oligodendrogliomas, but mechanistic links to pathogenesis are unclear. To address this question, we generated Cic-deficient mice and human oligodendroglioma cell models. Genetic deficiency in mice resulted in a partially penetrant embryonic or perinatal lethal phenotype, with the production of an aberrant proliferative neural population in surviving animals. In vitro cultured neural stem cells derived from Cic conditional knockout mice bypassed an EGF requirement for proliferation and displayed a defect in their potential for oligodendrocyte differentiation. Cic is known to participate in gene suppression that can be relieved by EGFR signal, but we found that cic also activated expression of a broad range of EGFR-independent genes. In an orthotopic mouse model of glioma, we found that Cic loss potentiated the formation and reduced the latency in tumor development. Collectively, our results define an important role for Cic in regulating neural cell proliferation and lineage specification, and suggest mechanistic explanations for how CIC mutations may impact the pathogenesis and therapeutic targeting of oligodendroglioma. Cancer Res; 77(22); 6097-108. ©2017 AACR.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligodendroglioma / Proteínas Repressoras / Diferenciação Celular / Proliferação de Células / Células-Tronco Neurais / Mutação Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligodendroglioma / Proteínas Repressoras / Diferenciação Celular / Proliferação de Células / Células-Tronco Neurais / Mutação Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article